tiprankstipranks
Trending News
More News >
Advertisement

CGIE - ETF AI Analysis

Compare

Top Page

CGIE

Capital Group International Equity ETF (CGIE)

Rating:64Neutral
Price Target:
CGIE, the Capital Group International Equity ETF, has a solid overall rating, reflecting a portfolio led by strong global companies like TSMC and AstraZeneca, which benefit from robust financial performance, positive earnings, and strategic positioning in growth areas such as advanced technology and healthcare. However, some holdings like Airbus and Rolls-Royce face issues such as bearish technical trends, supply chain or financial stability challenges, which can weigh on the fund’s rating. The main risk factor is its exposure to individual international companies that may experience overvaluation, cash flow pressures, or sector-specific headwinds, adding volatility to the ETF.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Strong Leading Holdings
Several of the largest positions, including ASML, Safran, Rolls-Royce, TSMC, and Airbus, have delivered strong or steady performance, helping support the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries such as Japan, the UK, France, the U.S., and others, which helps reduce reliance on any single market.
Negative Factors
Above-Average Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which means more of the returns are used to cover fees.
Sector Concentration in Industrials and Financials
A large portion of the portfolio is invested in industrial and financial companies, which could hurt performance if these sectors face a downturn.
Mixed Performance Among Top Holdings
Some key positions, such as AstraZeneca and UniCredit, have shown weak or slightly negative performance, which can drag on overall returns.

CGIE vs. SPDR S&P 500 ETF (SPY)

CGIE Summary

The Capital Group International Equity ETF (CGIE) is a global stock fund that invests in companies outside the U.S., with big exposure to countries like Japan, the UK, and France. It doesn’t track a set index, but instead uses Capital Group’s research to pick a mix of industrial, financial, and technology companies of all sizes. Well-known holdings include ASML and AstraZeneca. Someone might invest in CGIE to diversify beyond the U.S. and tap into growth in both developed and emerging markets. A key risk is that international stocks can be volatile and can go up or down with global market and currency swings.
How much will it cost me?The Capital Group International Equity ETF (CGIE) has an expense ratio of 0.54%, meaning you’ll pay $5.40 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, which typically involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The CGIE ETF, with its focus on developed markets outside the U.S. and strong exposure to sectors like Industrials, Financials, and Technology, could benefit from global economic growth, technological advancements, and increased infrastructure spending. However, it may face challenges from rising interest rates, geopolitical tensions, or slower growth in key regions like Europe, which could negatively impact its top holdings and sector performance.

CGIE Top 10 Holdings

CGIE’s story is being written largely by Europe’s industrial and tech heavyweights. ASML and TSMC are doing the heavy lifting, with rising chip demand giving the fund a solid tech backbone. Aerospace names like Safran, Rolls-Royce, and Airbus are also pulling their weight, helping the industrial side hum along. On the softer side, AstraZeneca has been more mixed, occasionally losing steam and tempering gains. Overall, this is a developed-markets, ex-U.S. play with a clear tilt toward European industrials and semiconductors.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV4.35%$75.86M€464.34B67.81%
76
Outperform
SAFRAN SA3.01%$52.49M€123.85B28.07%
67
Neutral
AstraZeneca2.66%$46.40M£210.86B18.97%
80
Outperform
Rolls-Royce Holdings2.61%$45.45M£102.13B124.42%
71
Outperform
TSMC2.48%$43.22M$1.46T63.13%
81
Outperform
2.47%$43.05M
Skandinaviska Enskilda Banken AB2.30%$40.19Mkr385.63B22.69%
71
Outperform
2.29%$39.91M
ABB Ltd2.19%$38.18Mkr1.40T30.17%
78
Outperform
UniCredit SpA2.15%$37.53M€114.41B85.13%
75
Outperform

CGIE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
35.04
Positive
100DMA
34.46
Positive
200DMA
33.21
Positive
Market Momentum
MACD
0.38
Positive
RSI
54.50
Neutral
STOCH
56.45
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CGIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.17, equal to the 50-day MA of 35.04, and equal to the 200-day MA of 33.21, indicating a neutral trend. The MACD of 0.38 indicates Positive momentum. The RSI at 54.50 is Neutral, neither overbought nor oversold. The STOCH value of 56.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CGIE.

CGIE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.75B0.54%
$5.41B0.28%
$5.28B0.39%
$4.52B0.42%
$1.25B0.50%
$1.01B0.24%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CGIE
Capital Group International Equity ETF
36.14
7.68
26.99%
DIHP
Dimensional International High Profitability ETF
DFIS
Dimensional International Small Cap ETF
DISV
Dimensional International Small Cap Value ETF
TOUS
T. Rowe Price International Equity ETF
DFSI
Dimensional International Sustainability Core 1 ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement